Chimerix Market Capitalization from 2010 to 2024
| CMRX Stock | USD 0.89 0.01 1.11% |
Check Chimerix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chimerix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.5 K, Interest Expense of 3.2 M or Selling General Administrative of 20.2 M, as well as many indicators such as Price To Sales Ratio of 276, Dividend Yield of 0.0 or PTB Ratio of 0.42. Chimerix financial statements analysis is a perfect complement when working with Chimerix Valuation or Volatility modules.
Chimerix | Market Capitalization |
Latest Chimerix's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Chimerix over the last few years. It is Chimerix's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chimerix's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 80.94 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Chimerix Market Capitalization Regression Statistics
| Arithmetic Mean | 315,453,708 | |
| Geometric Mean | 238,315,183 | |
| Coefficient Of Variation | 97.23 | |
| Mean Deviation | 176,157,461 | |
| Median | 291,735,146 | |
| Standard Deviation | 306,731,247 | |
| Sample Variance | 94084.1T | |
| Range | 1.2B | |
| R-Value | (0.32) | |
| Mean Square Error | 91186.2T | |
| R-Squared | 0.10 | |
| Significance | 0.25 | |
| Slope | (21,692,378) | |
| Total Sum of Squares | 1317176.8T |
Chimerix Market Capitalization History
About Chimerix Financial Statements
Chimerix investors use historical fundamental indicators, such as Chimerix's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Chimerix. Please read more on our technical analysis and fundamental analysis pages.
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.